APVO
Price:
$0.282
Market Cap:
$2.66M
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company's preclinical candidates also include ALG.APV-527, an investigational bispecific ADAPTIR candidate that features a mechanism of action to target 4-1BB (CD137) and 5T4, a tumor antigen expressed in various types of cancers; and APVO603, a dual agonist bispecific antibody to target 4-1BB and OX40. It also develoes APVO44...[Read more]
Industry
Biotechnology
IPO Date
2016-07-20
Stock Exchange
NASDAQ
Ticker
APVO
According to Aptevo Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.77. This represents a change of -24.90% compared to the average of 2.35 of the last 4 quarters.
The mean historical Current Ratio of Aptevo Therapeutics Inc. over the last ten years is 2.68. The current 1.77 Current Ratio has changed 6.51% with respect to the historical average. Over the past ten years (40 quarters), APVO's Current Ratio was at its highest in in the September 2017 quarter at 7.76. The Current Ratio was at its lowest in in the March 2015 quarter at 0.
Average
2.68
Median
2.70
Minimum
0.78
Maximum
5.14
Discovering the peaks and valleys of Aptevo Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Current Ratio = 5.14
Minimum Annual Increase = -71.63%
Minimum Annual Current Ratio = 0.78
Year | Current Ratio | Change |
---|---|---|
2023 | 2.64 | -16.29% |
2022 | 3.15 | 108.46% |
2021 | 1.51 | -53.47% |
2020 | 3.25 | 314.43% |
2019 | 0.78 | -71.63% |
2018 | 2.76 | -46.18% |
2017 | 5.14 | 40.58% |
2016 | 3.65 | 107.41% |
2015 | 1.76 | -15.90% |
2014 | 2.09 | Infinity% |
The current Current Ratio of Aptevo Therapeutics Inc. (APVO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.43
5-year avg
2.27
10-year avg
2.68
Aptevo Therapeutics Inc.’s Current Ratio is less than Kronos Bio, Inc. (8.49), less than Cyclerion Therapeutics, Inc. (3.68), less than Larimar Therapeutics, Inc. (13.10), less than Addex Therapeutics Ltd (4.97), less than Achilles Therapeutics plc (8.24), less than Nutriband Inc. (0), less than Quoin Pharmaceuticals, Ltd. (6.57), less than Longeveron Inc. (3.35), less than RenovoRx, Inc. (4.18), less than Virax Biolabs Group Limited (4.39), less than Passage Bio, Inc. (25.94), less than Magenta Therapeutics, Inc. (7.67), less than TRACON Pharmaceuticals, Inc. (14.64), greater than Invivyd, Inc. (0.66), less than Avenue Therapeutics, Inc. (4.71), less than Hoth Therapeutics, Inc. (4.30), less than Revelation Biosciences, Inc. (14.62), greater than NeuroBo Pharmaceuticals, Inc. (1.10), less than null (2.94),
Company | Current Ratio | Market cap |
---|---|---|
8.49 | $57.28M | |
3.68 | $7.14M | |
13.10 | $483.02M | |
4.97 | $18.06M | |
8.24 | $42.12M | |
0 | $64.53M | |
6.57 | $2.86M | |
3.35 | $31.02M | |
4.18 | $24.95M | |
4.39 | $8.86M | |
25.94 | $37.34M | |
7.67 | $42.44M | |
14.64 | $136.30K | |
0.66 | $107.42M | |
4.71 | $3.15M | |
4.30 | $6.14M | |
14.62 | $3.19M | |
1.10 | $21.47M | |
2.94 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptevo Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aptevo Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Aptevo Therapeutics Inc.'s Current Ratio?
How is the Current Ratio calculated for Aptevo Therapeutics Inc. (APVO)?
What is the highest Current Ratio for Aptevo Therapeutics Inc. (APVO)?
What is the 3-year average Current Ratio for Aptevo Therapeutics Inc. (APVO)?
What is the 5-year average Current Ratio for Aptevo Therapeutics Inc. (APVO)?
How does the current Current Ratio for Aptevo Therapeutics Inc. (APVO) compare to its historical average?